Candida vaginitis in non-pregnant patients: A study of antifungal susceptibility testing and virulence factors

References

• Biasoli MS, Tosello ME, Luque AG, Magaró HM. 2010. Adherence, colonization and dissemination of Candida dubliniensis and other Candida species. Medical Mycology 48:291–297.
   PubMed Web of Science ®Google Scholar
• Boriollo MF, Bassi RC, dos Santos Nascimento CM, Feliciano LM, Francisco SB, Barros LM, et al. 2009. Distribution and hydrolytic enzyme characteristics of Candida albicans strains isolated from diabetic patients and their non-diabetic consorts. Oral Microbiology and Immunology 24:437–450.
   PubMedGoogle Scholar
• Chong PP, Abdul Hadi SR, Lee YL, Phan CL, Tan BC, Ng KP, et al. 2007. Genotyping and drug resistance profile of Candida spp. in recurrent and one-off vaginitis, and high association of non-albicans species with non-pregnant status. Infection, Genetics and Evolution 7:449–456.
   PubMedGoogle Scholar
• Clinical Laboratory Standards Institution. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard CLSI document M27-A3. Wayne, PA, 2008.
   Google Scholar
• Costa CR, Passos XS, e Souza LKH, Lucena Pde A, Fernandes Ode F, Silva Mdo R, et al. 2010. Differences in exoenzyme production and adherence ability of Candida spp. isolates from catheter, blood and oral cavity. Revista do Instituto de Medicina Tropical de Sao Paulo 52:139–143.
   PubMed Web of Science ®Google Scholar
• das Neves J, Pinto E, Teixeira B, Dias G, Rocha P, Cunha T, et al. 2008. Local treatment of vulvovaginal candidosis: general and practical considerations. Drugs 68:1787–1802.
   PubMed Web of Science ®Google Scholar
• Fan SR, Liu XP. 2011. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. Mycoses 54:501–505.
   PubMed Web of Science ®Google Scholar
• Ferrer J. 2000. Vaginal candidosis: epidemiological and etiological factors. International Journal of Gynecology and Obstetrics 71: s21–s27.
   PubMed Web of Science ®Google Scholar
• Galán-Ladero A, Blanco MT, Sacristán B, Fernández-Calderón MC, Pérez-Giraldo C, Gómez-Garcia AC. 2010. Enzymatic activities of Candida tropicalis isolated from hospitalized patients. Medical Mycology 48:207–210.
   PubMed Web of Science ®Google Scholar
• Gurcan S, Alver O, Ercan I, Ener B. 2010. Evaluation of virulence in various Candida species: in vitro and in vivo study. Turkish Journal of Medical Sciences 30:1493–1502.
   Google Scholar
• Guzel AB, Ilkit M, Akar T, Burgut R, Demir SC. 2011. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species. Medical Mycology 49:16–25.
   PubMed Web of Science ®Google Scholar
• Ilkit M, Guzel AB. 2011. The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: A mycological perspective. Critical Reviews in Microbiology 37:250–261.
   PubMed Web of Science ®Google Scholar
• Kalkanci A, Bozdayi G, Biri A, Kustimur S. 2005. Distribution of secreted aspartyl proteinases using a polymerase chain reaction assay with SAP specific primers in Candida albicans isolates. Folia Microbiologica 50:409–413.
   PubMed Web of Science ®Google Scholar
• Lian CH, Liu WD. 2007. Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis. Mycoses 50: 383–390.
   PubMed Web of Science ®Google Scholar
• Luo G, Samaranayake LP, Yau JY. 2001. Candida species exhibit differential in vitro hemolytic activities. Journal of Clinical Microbiology 39: 2971–2974.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Andes D, Diekema DJ, Espinell-Ingroff A, Sheehan D; CLSI Subcommittee for Antifungal Susceptibility Testing. 2010. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resistance Updates 13:180–195.
   PubMed Web of Science ®Google Scholar
• Price MF, Wilkinson ID, Gentry LO. 1982. Plate method for detection of phospholipase activity in Candida albicans. Sabouradia 20:7–14.
   PubMedGoogle Scholar
• Ray D, Goswami R, Banarjee U, Dadhal V, Goswami D, Mandal P, et al. 2007. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Diabetes Care 30:312–317.
   PubMed Web of Science ®Google Scholar
• Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. Journal of Clinical Microbiology 43:2155–2162.
   PubMed Web of Science ®Google Scholar
• Rüchel R, Böning B, Borg M. 1986. Characterization of a secretory proteinase of Candida parapsilosis and evidence for the absence of the enzyme during infection in vitro. Infection and Immunity 53:411–419.
   PubMed Web of Science ®Google Scholar
• Sacristán B, Blanco MT, Galán-Ladero A, Blanco J, Pérez-Giraldo C, Gómez-García AC. 2011. Aspartyl proteinase, phospholipase, hemolytic activities and biofilm production of Candida albicans isolated from bronchial aspirates of ICU patients. Medical Mycology 49:94–97.
   PubMed Web of Science ®Google Scholar
• Seider K, Heyken A, Lüttich A, Miramón P, Hube B. 2010. Interaction of pathogenic yeasts with phagocytes: survival, persistence and escape. Current Opinion in Microbiology 13:392–400.
   PubMed Web of Science ®Google Scholar
• Sobel JD. 2007. Vulvovaginal candidosis. Lancet 369:1961–1971.
   PubMed Web of Science ®Google Scholar
• Taylor BN, Staib P, Binder A, Biesemeier A, Sehnal M, Röllinghoff M, et al. 2005. Profile of Candida albicans-secreted aspartic proteinase elicited during vaginal infection. Infection and Immunity 73:1828–1835.
   PubMed Web of Science ®Google Scholar
• Tosun I, Aydin F, Kaklikkaya N, Erturk M. 2005. Induction of secretory aspartyl proteinase of Candida albicans by HIV-1 but not HSV-2 or some other microorganisms associated with vaginal environment. Mycopathologia 159:213–218.
   PubMed Web of Science ®Google Scholar
• Tsang CSP, Chu FCS, Leung WK, Jin LJ, Samaranayake LP, Siu SC. 2007. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. Journal of Medical Microbiology 56:1393–1398.
   PubMed Web of Science ®Google Scholar
• Yildirim Z, Kilic N, Kalkanci A. 2011. Fluorometric determination of acid proteinase activity in Candida albicans strains from diabetic patients with vulvovaginal candidiasis. Mycoses 54:e463–e467.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Takano M, Murakami M, Tanaka H, Matsuhisa A, Nakao N, et al. 1999. Characterization of a haemolytic factor from Candida albicans. Microbiology 145:689–694.
   PubMed Web of Science ®Google Scholar
• Zhu W, Filler SG. 2010. Interactions of Candida albicans with epithelial cells. Cellular Microbiology 12:273–282.
   PubMed Web of Science ®Google Scholar